Insiders DMK Pharmaceuticals Corporation

Equities

DMKPQ

US00547W3079

Market Closed - OTC Markets Other stock markets 03:53:07 2024-04-26 pm EDT			5-day change	1st Jan Change
0.035 ^USD	-2.78%		-30.42%	-95.00%

Apr. 11	North American Morning Briefing : Stock Futures Edge Lower Ahead of PPI Inflation Gauge	DJ
Apr. 04	North American Morning Briefing : Focus Turns to -2-	DJ

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

DMK Pharmaceuticals Corporation Announces Board Appointments	Jan. 31	CI
DMK Pharmaceuticals Corporation Announces Executive Changes	23-10-19	CI
Adamis Pharmaceuticals Changes Name to DMK Pharmaceuticals	23-09-07	MT
Adamis Pharmaceuticals Corporation has Changed its Name to DMK Pharmaceuticals Corporation	23-09-06	CI
Adamis Pharmaceuticals Corporation Announces Resignation of David C. Benedicto as Principal Accounting Officer	23-07-24	CI
Adamis Pharmaceuticals Completes Merger With DMK Pharmaceuticals	23-05-25	MT
Adamis Pharmaceuticals Corporation Announces CEO Changes	23-02-27	CI
Adamis Pharmaceuticals Corporation Announces Board Changes	23-02-27	CI
Adamis Pharmaceuticals Corporation Announces Resignation of Ronald B. Moss as Chief Medical Officer	22-10-04	CI
Adamis Pharmaceuticals Corporation Appoints Vickie Reed to Board of Directors	22-05-26	CI
Adamis Pharmaceuticals Appoints Chief Business Officer David Marguglio as CEO	22-05-18	MT
Adamis Pharmaceuticals Announces Leadership Transition to Support New Phase of Innovation and Growth	22-05-18	CI
Adamis Pharmaceuticals Announces Executive Changes	22-05-18	CI
Richard C. Williams Notifies Adamis Pharmaceuticals Corporation That Effective April 15, 2022, He Will Be Retiring	22-03-03	CI
Adamis Pharmaceuticals Corporation Announces Appointment of Meera Desai, Ph.D., to Board of Directors	21-10-04	CI
Adamis Pharmaceuticals Corporation Announces Resignation of Roshawn A. Blunt as Director, Effective October 1, 2021	21-09-13	CI
Adamis Announces Appointment CFO Changes	21-08-24	CI
Adamis Pharmaceuticals Corporation Announces Executive Changes	21-05-27	CI
Adamis Pharmaceuticals Corporation Announces Resignation of William C. Denby as Director, Member of the Audit Committee, Compensation Committee and Nominating and Governance Committee of	19-10-04	CI
Adamis Pharmaceuticals Corporation Announces Executive Changes	19-08-26	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders DMK Pharmaceuticals Corporation

Equities

DMKPQ

US00547W3079

Insiders

Filters